Berkshire Asset Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,000
Closed -$257K 302
2024
Q3
$257K Hold
15,000
0.01% 249
2024
Q2
$257K Buy
+15,000
New +$257K 0.01% 250